Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-075098
Filing Date
2011-08-09
Accepted
2011-08-09 16:16:33
Documents
10
Period of Report
2011-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y91358e10vq.htm 10-Q 440290
2 EX-31.1 y91358exv31w1.htm EX-31.1 12106
3 EX-32.1 y91358exv32w1.htm EX-32.1 6831
10 GRAPHIC y91358y9135800.gif GRAPHIC 4343
  Complete submission text file 0000950123-11-075098.txt   4962971

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT jnj-20110703.xml EX-101.INS 804422
5 EX-101 SCHEMA DOCUMENT jnj-20110703.xsd EX-101.SCH 48353
6 EX-101 CALCULATION LINKBASE DOCUMENT jnj-20110703_cal.xml EX-101.CAL 78680
7 EX-101 LABELS LINKBASE DOCUMENT jnj-20110703_lab.xml EX-101.LAB 380080
8 EX-101 PRESENTATION LINKBASE DOCUMENT jnj-20110703_pre.xml EX-101.PRE 263687
9 EX-101 DEFINITION LINKBASE DOCUMENT jnj-20110703_def.xml EX-101.DEF 145608
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0209
Type: 10-Q | Act: 34 | File No.: 001-03215 | Film No.: 111020994
SIC: 2834 Pharmaceutical Preparations